In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Homeopaths Worldwide Unite Against Swelling Tide Of Criticism

Executive Summary

In the last 12 months homeopathy has come under fire from groups across the world. However, homeopathy advocates in France, the UK, Australia and India are fighting back.

You may also be interested in...



More Than 70% Of US Physicians Recommend Supplements From Peer-Reviewed Study Evidence

Analysis of data from 2012 National Ambulatory Medical Care Survey Physician Induction Interview explored factors influencing physicians' decisions on recommending dietary supplements and other complementary health care products and services.

Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy

The Pharmaceutical Society of Australia has called on the country's pharmacy banner and buying groups to help remove homeopathic products from the shelves of Australian community pharmacies, thereby joining an international chorus of voices that has emerged over the last year questioning the efficacy of these treatments.

NHS 10-Year Plan A ‘Missed Opportunity’, Says PAGB

The UK’s consumer healthcare industry association, the Proprietary Association of Great Britain (PAGB), says that National Health Service (NHS) England has “missed an opportunity” by not placing self-care at the center of its new ‘Long Term Plan’.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel